Core Viewpoint - The Ministry of Industry and Information Technology has announced the preliminary list of the first batch of key cultivation pilot platforms, with a total of 242 platforms selected nationwide, covering essential fields for high-quality development in manufacturing [1][3]. Summary by Relevant Sections Pilot Platforms Overview - A total of 242 pilot platforms have been selected, categorized as follows: 79 in raw materials industry, 62 in consumer goods industry, 60 in equipment manufacturing, 21 in information technology, 13 in emerging and future industries, and 7 in common demand fields [3]. Equipment Manufacturing Sector - In the equipment manufacturing sector, 8 instrument and meter pilot platforms have been included, such as: - China Sensor Valley Intelligent Sensor Pilot Platform - Automotive Sensor Pilot Platform - Instrument Functional Materials and Special Sensors Pilot Platform - High-Precision Grating Scale Manufacturing and Application Pilot Platform - Nuclear Power Plant Instrument Pilot Platform - Beijing Jingyi High-End Instruments and Meters Pilot Platform - Guangdong Precision Instruments Advanced Manufacturing Technology Pilot Platform - Mechanical Industry Instrument Comprehensive Research Institute MEMS Sensor Pilot Platform [3][4]. Consumer Goods Industry - In the consumer goods industry, 33 pharmaceutical pilot platforms have been selected, including: - Liaoning Shangyao Northern Pharmaceutical Chemical Pilot Platform - Gene Engineering Drug Clinical Test Sample Preparation Pilot Platform - Innovative Drug Pilot Platform - Various medical device pilot platforms such as the West Lake IBT Biological Intelligence Pilot Platform and Regenerative Medicine Technology and Material Transformation Pilot Platform [5][6]. Medical Devices Sector - The medical devices sector includes 7 pilot platforms, such as: - West Lake IBT Biological Intelligence Pilot Platform - Medical Device Preclinical Animal Testing Safety Efficacy Verification and Inspection Testing Pilot Platform - Blood Dialysis Machine Pilot Platform - Beijing High-End Medical Device CDMO Pilot Platform - Regenerative Medicine Technology and Material Transformation Pilot Platform [7][8].

导读： 安捷伦推出InfinityLab ProiQ系列液质检测系统，涵盖Pro iQ与Pro iQPlus，支持多种分子分析，提升效率与精准度。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2025 年 5 月 28 日 ， 安 捷 伦 宣 布 推 出 液 质 检 测 领 域 的 最 新 创 新 成 果 ： Agi lent Infinit yLab Pro iQ 系 列 ， 包 括 Infinit yLab Pro iQ 与 Infinit yLab Pro iQ Plus。两款先进的智能系统通过差异化功能设计，满足现代实验室多样化的分析需求，尤其适用于分析小分子、寡核苷 酸、多肽和蛋白质等关键分子。 Pro iQ系列广泛覆盖制药与生物制药研发、化学和特种材料制造、学术及政府科研三大核心领域，同时深度赋能环境监测、食品安全等检测场 景。该系列产品凭借精度、灵敏度和智能设计，支持质量数确认、杂质分析、生物分子表征、痕量污染物检测和化合物纯化等应用，助力科学 家在常规和高级分析工作流程中取得高质量、可靠的结果。 安捷伦副总裁兼液相事业部 ...

特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 安捷伦科技公司近日宣布，Au g u st Sp e c h t将被任命为首席技术官。Sp e c h t之前是Th e rmo Fis h e r Sc i e n tifi c公司色谱和质谱事业部全球研发副 总裁，将于6月9日加入安捷伦。 安捷伦总裁兼首席执行官Pa d r a i g McDo n n e ll表示："我们很高兴欢迎Au g u st Sp e c h t加入安捷伦团队。Au g u st拥有超过2 5年的设计、开发和营 销分析仪器、软件和消耗品的经验，这些产品助力着全球的科学进步。他的工作体现了对科学界不断变化需求的深刻理解，以及提供帮助客户 将伟大科学转化为现实的创新解决方案的承诺。" 在加入生命科学集团之前， Spe cht曾The rmo Fishe r Sc i entifi c和Va r i an Inst ruments担任研发、产品管理、战略规划及业务发展等多个领 导职务 。 更多人事变动消息 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ...

导读： 安捷伦8850气相色谱仪升级，兼容质谱系统，提升分析效率与通量，适用于多种实验室场景。本次同步推出扩展的温度范围、CTC PAL3系列2自动 进样器系统兼容方案、多模式进样口（MMI）以及反吹功能。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 安捷伦8850气相色谱仪采用高达300 °C每分钟的柱温箱升温速率和快速冷却技术，显著提升分析通量并缩短周转时间。与其他台式气相色谱 系统相比，8850气相色谱仪的功耗降低了 45%，可帮助分析实验室实现可持续发展目标并节省能源成本。结合 5977C、7000E或7010D MS系统使用时，8850气相色谱仪可同步实现高速分析、智能化仪器管理及空间与能耗的大幅优化，成为高性能分析与环保实验室的理想之 选。 欢迎参加 At Home on Any Bench: High-Performance GC/MS for Ever y Lab （随需而变：全场景适配的高性能GC/MS）网络研 讨会，深入了解如何使用8850气相色谱仪节省空间和时间，同时提高效率与通量。 安捷伦8850气相色谱仪与质谱 ...

来源：弈赫市场咨询 北京弈赫国际信息咨询有限公司是一家业务覆盖全球的利基市场信息咨询公司，研究涉及了21个主要行业和1200个利基市场，覆盖了70多个国 家，一直致力于产出专业严谨的行业趋势分析，数据洞察，市场研究和解决方案。百度搜索yiheconsult或者弈赫咨询，访问官网获得免费报告样 本。 北京弈赫咨询最近发布了关于美容仪器2025市场深度分析报告，包括全球与中国版本。该报告通过对行业长期跟踪研究，帮助客户理解未来市场走向及趋 势。根据客户需求，报告可以进行定制，提升其针对性与实用性。同时，感兴趣的用户可以申请获得免费样本，便于更好地评估报告内容。 美容仪器的产业链可分为原材料供应、生产制造、分销渠道以及最终客户使用多个环节。上游原材料的选择直接影响到产品的品质与成本，而生产制造则是 将科技创新转化为实际产品的关键阶段。分销渠道的有效性决定了产品能否快速进入市场并为消费者所接受。最终，消费者的反馈不仅影响企业的销售业 绩，更是推动行业进步的重要动力。报告中将对这一产业链进行更为细致的分析，揭示各环节之间的相互影响和合作关系。 根据报告的研究数据，美容仪器市场正处于快速增长阶段，预计到2025年市场规模 ...

Core Viewpoint - Fuhuang Steel Structure is actively seeking industrial upgrades amid pressure on its traditional business by acquiring 100% of Zhongke Vision for 1.14 billion yuan and raising up to 400 million yuan from specific investors [1][2] Company Overview - Fuhuang Steel Structure's main business includes steel structure processing and manufacturing, focusing on heavy and light steel structures, solid wood composite doors, and high-end windows and doors, primarily used in large industrial plants, high-rise buildings, exhibition centers, municipal bridges, and residential buildings [1] - Zhongke Vision specializes in high-speed visual perception and measurement technology, with its main products including high-speed cameras and various visual measurement and analysis systems [1] Strategic Shift - The acquisition marks a significant strategic shift for Fuhuang Steel Structure, transitioning its focus from steel structure business to the technology sector, aiming to optimize resource allocation and develop a high-tech company centered on high-speed vision [2] Financial Performance - Zhongke Vision's financial performance is underwhelming, with projected revenues of 191 million yuan and 222 million yuan for 2023 and 2024, respectively, and net profits of 15.54 million yuan and 15.45 million yuan, indicating a decline in net profit despite revenue growth in 2024 [2] - As of December 31, 2024, Zhongke Vision's net asset value is 391 million yuan, with a valuation of 1.14 billion yuan, reflecting a significant increase of 748 million yuan and a valuation increase rate of 191.22% [2] Recent Performance - Fuhuang Steel Structure has faced declining operating revenue and net profit from 2022 to 2024, but showed signs of recovery in Q1 2025 with revenues of 933 million yuan and net profits of 17.42 million yuan, representing year-on-year growth of 1.65% and 4.04%, respectively [2] Profit Commitment - Zhongke Vision has committed to achieving net profits of no less than 33.33 million yuan, 50.72 million yuan, and 73.11 million yuan for the years 2025, 2026, and 2027, respectively, with a cumulative target of at least 157 million yuan over three years [3]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $1,670 million, representing a 6% reported growth and a 5.3% core growth compared to Q2 2024 [6][26] - Operating margin was 25.1%, and EPS was $1.31, growing 7% year over year [6][32] - The company experienced its fourth consecutive quarter of accelerating growth [7] Business Line Data and Key Metrics Changes - The Agilent CrossLab Group reported revenue of $713 million, growing 9% [27] - Life Sciences and Diagnostics Market Group revenue was $654 million, growing 3% [28] - Applied Markets Group revenue was flat at $300 million on a core growth basis [28] Market Data and Key Metrics Changes - All regions experienced growth: Americas grew low single digits, EMEA grew mid single digits, and China led with 10% growth [9][11] - India delivered high teens growth, and the company opened its first solution center in India [11] - PFAS testing grew more than 70% year over year globally, with Europe and China more than doubling their business [13][14] Company Strategy and Development Direction - The company is executing its three-year Ignite transformation strategy, which has resulted in early wins and tariff mitigation [8][20] - Agilent is focused on innovation and has launched several new products, including the Seahorse XF Flex analyzer and the InfinityLab Pro IQ series [22][23] - The company is committed to maintaining a strong balance sheet and exploring external growth opportunities [41] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about long-term growth prospects, maintaining a core growth rate of 2.5% to 3.5% for the year [25][36] - The company is proactively managing tariff exposure and expects to fully mitigate costs by fiscal 2026 [24][37] - Despite exceeding expectations in Q2, management emphasizes the importance of a disciplined outlook due to ongoing macroeconomic uncertainties [26] Other Important Information - The company has a robust pipeline of opportunities aligned with its strategy and is focused on augmenting internal innovation with external growth [41] - Agilent's digital orders grew by 12% year over year to $295 million [16] Q&A Session Summary Question: Can you provide insights on order trends during the quarter? - Orders grew low single digits in Q2, with stable business across regions and no significant pull forward from pharma tariffs [47][48] Question: What are the expectations for the NASD and BioVectra businesses? - The CDMO business is seeing high single-digit growth, with confidence in double-digit growth for the second half of the year [50][53] Question: What was the impact of tariffs on consumables? - The $15 million of consumables pulled forward was due to customer anticipation of tariffs, with no overall revenue impact for Q2 [60][61] Question: How is the Infinity Tree replacement cycle performing? - The Infinity Tree ramp is strong, with positive customer feedback and increasing adoption rates [88][89] Question: What is the outlook for pricing in light of tariffs? - The company has achieved significant pricing contributions and expects to maintain pricing strategies to mitigate tariff impacts [83][85]

Core Viewpoint - 华盛昌 is actively engaged in the development of safety protection products for the petrochemical industry, with a focus on gas detection and environmental monitoring technologies [1][2]. Group 1: Product Offerings - 华盛昌 offers a diverse range of products for safety protection in the petrochemical sector, including: - GD-3806, a high-precision four-in-one combustible gas detector capable of detecting ammonia, hydrogen sulfide, carbon monoxide, oxygen, and explosive gas concentrations [1]. - CH-9980, a high-precision methane remote sensing device utilizing laser detection technology for non-contact methane leak monitoring [1]. - DT-1990H, a handheld multifunctional detection device that employs microphone array beamforming technology for real-time sound field data collection [1]. Group 2: Financial Information - As of May 28, 2025, 华盛昌's stock closed at 26.88 yuan, with a trading volume of 13,100 shares and a turnover of 35.27 million yuan [1]. - The company announced a cash dividend of 7.3 yuan per 10 shares (including tax) and a capital reserve increase of 4 shares for every 10 shares held, based on a total share capital of 134,759,400 shares [2][4]. - The total cash dividend distribution amounts to 98,374,362 yuan (including tax), and the capital increase will result in a total share capital of 189,141,160 shares post-distribution [2][4].

证券代码：831961 证券简称：创远信科 公告编号：2025-042 创远信科（上海）技术股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 5 月 28 日 活动地点：上海浦东新区 参会单位及人员：方正证券股份有限公司、中信证券股份有限公 司及其邀请的投资者 上市公司接待人员：董事会秘书、财务总监王小磊女士 三、 投资者关系活动主要内容 本次投资者关系活动的主要问题及公司对问题的回复概要如 下： 问题 1：请介绍一下公司最近中标通号低空智能科技有限公司 的关键性设备采购的具体情况？ 回复：您好！感谢您关注创远信科。公司已收到通号低空智能 科技有限公司低空空域智能通信系统关键设备谈判采购项目的中 标通知书，已成功中标低空空域智能通信系统关键设备，中标金额 人民币 115 万元整。 本次中标产品为 ...

Core Viewpoint - The company has announced its 2024 annual profit distribution plan, which includes a cash dividend of RMB 0.596928 per 10 shares, following the approval at the shareholders' meeting on May 13, 2025 [2][3]. Summary by Sections 1. Profit Distribution Plan - The cash dividend distribution plan involves a total payout of RMB 47,792,934.42, with no stock dividends or capital reserve transfers [3]. - The total share capital will increase from 796,548,907 shares to 800,646,907 shares due to the completion of the 2022 restricted stock incentive plan [3][4]. 2. Dividend Amount and Taxation - The cash dividend per 10 shares is set at RMB 0.596928 (including tax), with different tax treatments for various types of shareholders [3][4]. - For Hong Kong market investors and certain foreign institutions, the net dividend after tax will be RMB 0.537235 per 10 shares [3]. 3. Key Dates - The record date for the dividend distribution is June 5, 2025, and the ex-dividend date is June 6, 2025 [3][4]. 4. Distribution Method - Cash dividends will be directly credited to the shareholders' accounts through their securities companies or other custodians [4]. 5. Adjustments and Responsibilities - The company will adjust the grant price of the restricted stock incentive plan based on any changes in capital reserves or stock distributions prior to the vesting of the restricted stocks [5]. - The company assumes all legal responsibilities for any shortfall in cash dividends due to a decrease in shares held by shareholders during the distribution application period [5].